fashion -WSS

fashion

author：hotspot 2025-09-06 02:05:07 - browse：831

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： BridgeBio heart drug succeeds in pivotal study

WSS

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Dementia risk linked to living in disadvantaged areas: Study

Telehealth startups are trying to fill the menopause care vacuum

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Robert Kennedy Jr.'s presidential campaign attracts GOP

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

The high cost of giving birth even with insurance

Extensive review finds private equity owners jack up cost of care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why you get paid to donate plasma but not blood

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Jerome Adams on the need for new antivirals for Covid

Caribou posts encouraging results on off

Psychedelics group wrestles with new pharma identity

Johnson & Johnson sues to stop Medicare negotiation

focus

US soldier in North Korean custody after crossing DMZ line

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Are infertility treatments 'essential' during the Covid

More hospitals are billing patients as online messages surge

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

FDA seeking to stop procedures at two unregulated stem cell clinics

Wikipedia

leisure time

knowledge

knowledge